Elizabeth C. Liow

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian Cohorts.

Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian Cohorts.

Journal: JCO global oncology
Published: March 06, 2026

Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours.

Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours.

Journal: BJUI compass
Published: June 22, 2025

Impact of Immunotherapy Prescribing Restrictions on Time to Systemic Therapy and Outcomes in Metastatic Clear Cell Renal Carcinoma in Australia.

Impact of Immunotherapy Prescribing Restrictions on Time to Systemic Therapy and Outcomes in Metastatic Clear Cell Renal Carcinoma in Australia.

Journal: Asia-Pacific journal of clinical oncology
Published: April 23, 2025

Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma.

Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma.

Journal: European urology focus
Published: August 25, 2024

Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series.

Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series.

Journal: Asia-Pacific journal of clinical oncology
Published: August 21, 2024

The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancer.

The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancer.

Journal: BJU international
Published: March 12, 2024

A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.

A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.

Journal: BJU international
Published: November 21, 2023

Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort.

Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort.

Journal: Journal of geriatric oncology
Published: April 11, 2023

Treatment de-escalation for stage II seminoma.

Treatment de-escalation for stage II seminoma.

Journal: Nature reviews. Urology
Published: January 31, 2023

Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods Study.

Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods Study.

Journal: JMIR cancer
Published: May 19, 2022

Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy.

Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy.

Journal: Clinical genitourinary cancer
Published: April 25, 2022

89Zirconium-labelled girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma.

89Zirconium-labelled girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma.

Journal: BMJ open
Published: April 16, 2022
Showing 1-12 of 20

Last Updated: 09/26/2026